About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNPhase 4NCT01425164

Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol

In hemodialysed patients, coronary heart disease is the leading cause of mortality and morbidity. Most of the commonly used drug for ischemia are used in this patients, but few prospective data are av...

Lead sponsor: University of Campania Luigi Vanvitelli•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Gennaro Cice, MD

CONTACT

+390815666642 [email protected]

Sponsors

Lead Sponsor

University of Campania Luigi Vanvitelli

Collaborators

IRCCS San Raffaele

Age

30 - 85 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•documented CAD evidenced by either coronary angiography (\>50% diameter stenosis of a major coronary artery) or a previously documented myocardial infarction
•transient ischemia evidenced by abnormalities during an exercise ECG (standard Bruce protocol), myocardial perfusion scintigraphy, or stress regional wall motion study done within 6 months of study entry

Exclusion Criteria

•unstable angina pectoris
•myocardial infarction or coronary revascularization within 3 months of study entry
•an ECG abnormality interfering with exercise ST-segment interpretation (eg, ST-segment depression \>0.5 mm, QRS duration \>0.1 second, R-wave amplitude \<8 mm,preexcitation,or atrial fibrillation)
•inability to undergo exercise testing
•uncontrolled hypertension
•other serious condition (medical, psychiatric, cognitive, or social)
•symptoms of sufficient severity (Canadian class II or higher) to require antianginal medications other than nitrates
•heart failure
•greater than first-degree atrio-ventricular block, asthma, or other contraindications to betablocker therapy

Related studies

Efficacy of pHA130 Hemoadsorption on Protein-Bound Uremic Toxins and Quality of Life in Kidney Failure

NCT07656168 · ESRD (End-Stage Renal Disease), Maintenance Hemodialysis

CTCA Prior to Invasive Angiography in Post-Bypass Patients (BYPASS CTCA 2)

NCT07165678 · Coronary Heart Disease

PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis

NCT06422871 · End Stage Renal Disease, Hemodialysis Access Failure

RECRUITINGPhase 3

A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders

NCT07285291 · Hyperphosphatemia Patients on Hemodialysis

Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With Stable Angina or ACS - A Traditional Feasibility Study

NCT06939374 · Coronary Arterial Disease (CAD), Plaque, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 28, 2012Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE4

Enrollment220

Start dateJan 2011

Last updatedJun 28, 2012

Condition

Coronary Heart Disease Angina Hemodialysis

Locations shown

Chair of Cardiology Second University of Naples

Naples

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 28, 2012Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions